Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings

Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
By: market watch Posted On: May 21, 2024 View: 37

[unable to retrieve full-text content]

Hims & Hers Health’s stock jumped nearly 30% Monday after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.

Read this on market watch Header Banner
  Contact Us
  • Contact Form
  Follow Us
  About

Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.